公募基金抱团实验动物板块，规避创新药风险
2026-07-16 00:16:33
据证券时报报道，近期实验猴、实验鼠等实验动物相关板块行情持续升温，公募基金开始抱团重仓甚至举牌布局这些板块。医药基金经理借鉴新能源汽车行业布局车载芯片、规避投资整车的经验，通过投资上游研发服务企业，规避创新药公司面临的巨大投入和药物研发失败风险。多位基金经理强调，临床数据正成为检验创新药管线价值的硬标准，板块有望迎来业绩、估值双提升的新阶段。
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
Previous article：
法国通过法案 允许不治之症成年人“协助死亡”Next article：
长鑫科技回应IPO后再融资安排
